GB0523251D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0523251D0
GB0523251D0 GBGB0523251.7A GB0523251A GB0523251D0 GB 0523251 D0 GB0523251 D0 GB 0523251D0 GB 0523251 A GB0523251 A GB 0523251A GB 0523251 D0 GB0523251 D0 GB 0523251D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0523251.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0523251.7A priority Critical patent/GB0523251D0/en
Publication of GB0523251D0 publication Critical patent/GB0523251D0/en
Priority to PCT/EP2006/010894 priority patent/WO2007057152A1/en
Priority to US12/093,613 priority patent/US20080249077A1/en
Priority to JP2008539361A priority patent/JP2009515844A/ja
Priority to EP06818517A priority patent/EP1957512A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0523251.7A 2005-11-15 2005-11-15 Novel compounds Ceased GB0523251D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0523251.7A GB0523251D0 (en) 2005-11-15 2005-11-15 Novel compounds
PCT/EP2006/010894 WO2007057152A1 (en) 2005-11-15 2006-11-13 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent
US12/093,613 US20080249077A1 (en) 2005-11-15 2006-11-13 17.Beta.-Fluoromethoxycarbonyl-Androst-4-En-3-One Compounds With a 17.Alpha.-Carbonate Sustituent
JP2008539361A JP2009515844A (ja) 2005-11-15 2006-11-13 １７アルファ−カルボネート置換基を有する１７ベータ−フルオロメトキシカルボニル−アンドロスタ−４−エン−３−オン化合物
EP06818517A EP1957512A1 (en) 2005-11-15 2006-11-13 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0523251.7A GB0523251D0 (en) 2005-11-15 2005-11-15 Novel compounds

Publications (1)

Publication Number Publication Date
GB0523251D0 true GB0523251D0 (en) 2005-12-21

Family

ID=35516957

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0523251.7A Ceased GB0523251D0 (en) 2005-11-15 2005-11-15 Novel compounds

Country Status (5)

Country Link
US (1) US20080249077A1 (https=)
EP (1) EP1957512A1 (https=)
JP (1) JP2009515844A (https=)
GB (1) GB0523251D0 (https=)
WO (1) WO2007057152A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012056201A2 (en) 2010-10-27 2012-05-03 Hovione Inter Limited Electrophilic reagents for monohalomethylation,their preparation and their uses
WO2024149093A1 (zh) * 2023-01-10 2024-07-18 四川科伦博泰生物医药股份有限公司 糖皮质激素受体激动剂及其偶联物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA814440B (en) * 1980-07-10 1982-10-27 Otsuka Pharma Co Ltd Soft steroids having anti-inflammatory activity
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
JPS6041607A (ja) * 1983-08-12 1985-03-05 Otsuka Pharmaceut Co Ltd 軟膏基剤
DE4025342A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel
WO2005000317A1 (en) * 2003-06-19 2005-01-06 Bodor Nicholas S Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application
US20090124588A1 (en) * 2005-01-10 2009-05-14 Glaxo Group Limited Androstane 17-Alpha-Carbonate for Use in the Treatment of Inflammatory and Allergic Conditions
EP1841780B1 (en) * 2005-01-10 2011-07-27 Glaxo Group Limited Androstane 17-alpha-carbonate derivatives for use in the treatment of allergic and inflammatory conditions

Also Published As

Publication number Publication date
WO2007057152A1 (en) 2007-05-24
EP1957512A1 (en) 2008-08-20
US20080249077A1 (en) 2008-10-09
JP2009515844A (ja) 2009-04-16

Similar Documents

Publication Publication Date Title
AP2007004171A0 (en) Novel compounds
EP1868612A4 (en) NOVEL CONNECTIONS
EP1868611A4 (en) NOVEL CONNECTIONS
GB0503955D0 (en) Novel compounds
GB0500140D0 (en) Novel compounds
EP1869026A4 (en) NEW CONNECTIONS
GB0500923D0 (en) Novel compounds
GB0501961D0 (en) Novel compounds
GB0500284D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0500405D0 (en) Novel compounds
GB0500406D0 (en) Novel compounds
GB0500513D0 (en) Novel compounds
GB0500839D0 (en) Novel polyacetylen compounds
GB0500883D0 (en) Novel compounds
GB0500884D0 (en) Novel compounds
GB0500885D0 (en) Novel compounds
GB0500886D0 (en) Novel compounds
GB0503129D0 (en) Novel compounds
GB0500916D0 (en) Novel compounds
GB0500919D0 (en) Novel compounds
GB0500920D0 (en) Novel compounds
GB0500921D0 (en) Novel compounds
GB0503130D0 (en) Novel compounds
GB0500925D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)